insights_auto
Pse është ulur AMGN34 4,66%?
Zhytu më thellëchevron_right
AMGN34:BVMF
Amgen Inc. BDR
72,00Â BRL
arrow_downward
-4,66%(-3,52) 1D
5 tet, 4:56:00 m.d., GMT-3 · BRL
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për AMGN34...
Hap
71,87Â BRL
I lartë
72,16Â BRL
I ulët
71,09Â BRL
Kapitalizimi i tregut
217,86Â mld
Vëllimi mesatar
370,00
Vëllimi
1,21 mijë
Maksimumi 52-javor
83,06Â BRL
Minimumi 52-javor
47,76Â BRL
Aksionet në qarkullim
540,63Â mln
Numri i punonjësve
32 mijë
Hap
71,87Â BRL
I lartë
72,16Â BRL
I ulët
71,09Â BRL
Kapitalizimi i tregut
217,86Â mld
Vëllimi mesatar
370,00
Vëllimi
1,21 mijë
Maksimumi 52-javor
83,06Â BRL
Minimumi 52-javor
47,76Â BRL
Aksionet në qarkullim
540,63Â mln
Numri i punonjësve
32 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Kalkine Media
·
5 orë më parë
Why is Amgen (NASDAQ:AMGN) stock in focus as its obesity pipeline advances?
AD HOC NEWS
·
6 orë më parë
Amgen stock faces a USD 400 Cantor Fitzgerald target
MarketBeat
·
6 orë më parë
2,546 Amgen Inc. $AMGN Shares Sold by Argent Capital Management LLC
Investing.com
·
10 orë më parë
Cantor Fitzgerald reiterates Amgen stock Neutral rating at $400
Profili
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Rreth Amgen Inc. BDR
Drejtori ekzekutivRobert A. Bradway
Punonjësit31,5 mijë
Themeluar më1980
SeliaThousand Oaks, Kalifornia, Shtetet e Bashkuara të Amerikës
Sektori-
Uebsajtiamgen.com